Company Announcements

Fractyl Health Updates Clinical Studies and Corporate Slides

Fractyl Health, Inc. (GUTS) has provided an announcement.

Fractyl Health, Inc. issued a press release on June 24, 2024, providing updates on its clinical studies for weight maintenance and type 2 diabetes treatments. The company also updated its corporate slide presentation to reflect these recent developments, which is available on their investor relations website. This information, although not considered officially filed for regulatory purposes, offers insight into Fractyl’s ongoing research and business progress.

Find detailed analytics on GUTS stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskFractyl Health Unveils Promising Gene Therapy Data
TheFlyFractyl Health presented new analysis of Revita studies at ObesityWeek 2024
TheFlyFractyl Health participates in a conference call with Truist
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App